|
2022
|
Invention
|
Recombinant human epo-fc-fusion proteins with prolonged half-life and enhanced erythropoietic act... |
|
2021
|
Invention
|
Fusion proteins having mutated immunoglobulin hinge region.
A fusion protein having a non-immuno... |
|
2019
|
Invention
|
Recombinant human interferon-like proteins.
This application relates to recombinant human interf... |
|
2018
|
P/S
|
Proteins for use in the manufacture of pharmaceutical preparations for treating cancer and viral ... |
|
|
Invention
|
Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic act... |
|
|
Invention
|
Method of treating diseases with recombinant human interferon-like proteins. b). The invention en... |
|
2016
|
Invention
|
Recombinant human interferon-like proteins. This application relates to recombinant human interfe... |
|
2014
|
P/S
|
Pharmaceutical preparations for treatment of cancer, anti-viral pharmaceutical preparations for t... |
|
2013
|
Invention
|
Recombinant human interferon-like proteins and method of treatment using them. b). The invention ... |
|
2011
|
Invention
|
Fusion proteins having mutated immunoglobulin hinge region. A fusion protein having a non-immunog... |
|
2009
|
Invention
|
Polynucleotides encoding human epo-fc fusion proteins with prolonged half-life and enhanced eryth... |
|
2008
|
Invention
|
Fusion proteins. A fusion protein having a non-immunoglobulin polypeptide having a cysteine resid... |
|
2007
|
P/S
|
Pharmaceutical preparations; proteins, protein fragments; protein conjugates; anti-cancer and ant... |
